These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 39143176)

  • 21. [Molecular targeted therapy and genomic evolution of breast cancer].
    Sato F; Toi M
    Nihon Rinsho; 2015 Aug; 73(8):1364-72. PubMed ID: 26281691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breast tumours maintain a reservoir of subclonal diversity during expansion.
    Minussi DC; Nicholson MD; Ye H; Davis A; Wang K; Baker T; Tarabichi M; Sei E; Du H; Rabbani M; Peng C; Hu M; Bai S; Lin YW; Schalck A; Multani A; Ma J; McDonald TO; Casasent A; Barrera A; Chen H; Lim B; Arun B; Meric-Bernstam F; Van Loo P; Michor F; Navin NE
    Nature; 2021 Apr; 592(7853):302-308. PubMed ID: 33762732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breast cancer heterogeneity: parallel evolution or conscious uncoupling?
    Natrajan RC
    J Pathol; 2015 Sep; 237(1):1-3. PubMed ID: 25953517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revolutionary and evolutionary progress in breast cancer.
    Snyder RD
    Aust N Z J Med; 1997 Oct; 27(5):523-5. PubMed ID: 9404581
    [No Abstract]   [Full Text] [Related]  

  • 25. Case report: 16-yr life history and genomic evolution of an ER
    Xu B; Amallraja A; Swaminathan P; Elsey R; Davis C; Theel S; Viet S; Petersen J; Krie A; Davies G; Williams CB; Ehli E; Meißner T
    Cold Spring Harb Mol Case Stud; 2020 Dec; 6(6):. PubMed ID: 33008833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials.
    Beca F; Beck AH
    PLoS Med; 2016 Dec; 13(12):e1002177. PubMed ID: 27923047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genomic characterization of metastatic breast cancers.
    Bertucci F; Ng CKY; Patsouris A; Droin N; Piscuoglio S; Carbuccia N; Soria JC; Dien AT; Adnani Y; Kamal M; Garnier S; Meurice G; Jimenez M; Dogan S; Verret B; Chaffanet M; Bachelot T; Campone M; Lefeuvre C; Bonnefoi H; Dalenc F; Jacquet A; De Filippo MR; Babbar N; Birnbaum D; Filleron T; Le Tourneau C; André F
    Nature; 2019 May; 569(7757):560-564. PubMed ID: 31118521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Somatic Trp53 mutations differentially drive breast cancer and evolution of metastases.
    Zhang Y; Xiong S; Liu B; Pant V; Celii F; Chau G; Elizondo-Fraire AC; Yang P; You MJ; El-Naggar AK; Navin NE; Lozano G
    Nat Commun; 2018 Sep; 9(1):3953. PubMed ID: 30262850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlations between family history and cancer characteristics in 2256 breast cancer patients.
    Molino A; Giovannini M; Pedersini R; Frisinghelli M; Micciolo R; Mandarà M; Pavarana M; Cetto GL
    Br J Cancer; 2004 Jul; 91(1):96-8. PubMed ID: 15162141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular evolution of breast cancer.
    Simpson PT; Reis-Filho JS; Gale T; Lakhani SR
    J Pathol; 2005 Jan; 205(2):248-54. PubMed ID: 15641021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical characteristics of breast cancer patients with family history.
    Tsuchiya A; Kanno M; Nomizu T; Hatakeyama Y; Kimijima I; Abe R
    Fukushima J Med Sci; 1998 Jun; 44(1):35-41. PubMed ID: 9775529
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Family history and bilateral primary breast cancer.
    Chaudary MA; Millis RR; Bulbrook RD; Hayward JL
    Breast Cancer Res Treat; 1985; 5(2):201-5. PubMed ID: 4016285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ‘The charmingest place’: non-coding RNA, lineage tracing, tumor heterogeneity, metastasis and metabolism--new methods in mammary gland development and cancer: the fifth ENBDC Workshop.
    Clarke RB; Stingl J; Vivanco M; Bentires-Alj M
    Breast Cancer Res; 2013; 15(5):313. PubMed ID: 24103450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene expression sigantures, cancer cell evolution and metastatic progression.
    Klein CA
    Cell Cycle; 2004 Jan; 3(1):29-31. PubMed ID: 14657660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer intratumor genetic heterogeneity: causes and implications.
    Ng CK; Pemberton HN; Reis-Filho JS
    Expert Rev Anticancer Ther; 2012 Aug; 12(8):1021-32. PubMed ID: 23030222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular evolutionary patterns in breast cancer.
    Shackney SE; Silverman JF
    Adv Anat Pathol; 2003 Sep; 10(5):278-90. PubMed ID: 12973049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 mutations in breast cancer: incidence and relations to tumor aggressiveness and evolution of the disease.
    Bautista S; Theillet C
    Pathol Biol (Paris); 1997 Dec; 45(10):882-92. PubMed ID: 9769953
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing somatic events in the evolution of cancer.
    Jolly C; Van Loo P
    Genome Biol; 2018 Jul; 19(1):95. PubMed ID: 30041675
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent advances in breast cancer biology.
    Schultz LB; Weber BL
    Curr Opin Oncol; 1999 Nov; 11(6):429-34. PubMed ID: 10550005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Expression, Clinicopathologic Characteristics, and Prognostic Value of Androgen Receptor in Breast Cancer: A Bioinformatics Analysis Using Public Databases.
    Fu WF; Li JJ; Kang SH; Song CG
    DNA Cell Biol; 2020 May; 39(5):864-874. PubMed ID: 32181676
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.